Delivery Order SPE2DB20D7061-SPE2DB25FSPV1
- Not listed
- The Defense Logistics Agency awarded a $1,199.28 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Doxycycline Hyclate 100 mg tablets in quantities of 1,000 units. This is a firm fixed-price, non-set-aside contract with a completion date of September 11, 2025, and performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's significant role as a critical pharmaceutical...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Doxycycline Hyclate, an antibiotic medication. This firm fixed-price delivery order, valued at $4,243.50, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999.999 billion and extends through December 2026. The delivery order carries no...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 500 tablets of Doxycycline Hyclate 100 mg, valued at $1,121.97, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order was issued on August 5, 2025, with no set-aside designation. The product will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $1,000.28 to AmerisourceBergen Drug Corp for Doxycycline Hyclate 50 mg capsules (500-count supply) on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, non-set-aside contract employs firm fixed-price pricing and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 6, 2025, for the supply of Doxycycline Hyclate 100 mg tablets in quantities of 1,000 units, with a contract value of $1,085.95. This competitively awarded, non-set-aside delivery order carries a firm fixed price and an ultimate completion date of May 7, 2025. The contract is performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for doxycycline 100 mg vials valued at $1,661.08. This competitive award, issued on September 16, 2025, with an ultimate completion date of September 17, 2025, represents a firm fixed-price delivery order with no set-aside designation. The contract is performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania, the company's headquarters and primary distribution...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,736.07 to AmerisourceBergen Drug Corp for the procurement of Doxycycline Hyclate 100 mg tablets (1,000 count) on August 27, 2025, with an ultimate completion date of August 28, 2025. This delivery order was issued under a firm fixed price structure with no set-aside designation, awarded through open competition. The place of performance is listed as the vendor's corporate office location in Conshohocken, Pennsylvania. As...
- The Defense Logistics Agency awarded a competitive delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Doxycycline Hyclate 100 mg tablets in quantities of 1,000 units, with a ceiling value of $3,906.59 and a completion date of September 23, 2025. This non-set-aside contract reflects a firm fixed price arrangement for pharmaceutical delivery to support federal medical supply needs. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Doxycycline Hyclate 100 mg tablets (1,000 count) on July 15, 2025, with a ceiling value of $1,299.23 and ultimate completion by July 16, 2025. This firm fixed-price delivery order represents a small-value pharmaceutical transaction within the federal medical supply chain. The contract is not designated as a set-aside procurement and will be performed at AmerisourceBergen's facility in...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Doxycycline Hyclate, an antibiotic medication, valued at $5,131.87. The contract was competitively awarded without set-aside designation and is scheduled for completion by October 24, 2025. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 potential...
- SPE2DB20D7061Indefinite Delivery Contract
- SPE2DB20D7061-SPE2DB25FSPV1Delivery Order
The Defense Logistics Agency awarded a $17,147.50 firm fixed price delivery order to AmerisourceBergen Drug Corp for Doxycycline Hyclate 100 mg VLS on September 17, 2025, with an ultimate completion date of September 18, 2025. This non-set-aside award represents a competitively awarded delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. The point of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The delivery order for Doxycycline Hyclate—a broad-spectrum antibiotic—aligns with AmerisourceBergen's extensive portfolio of federal medical supply contracts, which encompass pharmaceuticals, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's DLA prime vendor contract enables flexible procurement of pharmaceutical products to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.1k | 9/17/25 |